🔎 Trials Near Me

Dachaigh › Cancers gastrointestinal › Massachusetts

Sgrùdaidhean clionaigeach Cancers gastrointestinal ann an Massachusetts

Tha 15 sgrùdaidhean airson Cancers gastrointestinal a’ lorg phàirtichean aig làraichean ann an Massachusetts.

Bailtean ann an Massachusetts

Teacsa sgrùdaidh oifigeil (Beurla)

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07544589

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

  • GSK Investigational Site, Boston
  • GSK Investigational Site, Boston
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07218926

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • Dana-Farber Cancer Institute - Oncology Department, Boston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06760819

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • Brigham and Women's Hospital (BWH), Boston
  • Dana-Farber Cancer Institute (DFCI), Boston
  • Dana-Farber Brigham Cancer Center - Foxborough, Foxborough
  • agus 2 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07222800

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06445062

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Dana Farber Cancer Institute, Boston
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06128551

SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)

  • Dana Farber Cancer Institute, Boston
  • Dana-Farber Cancer Institute at St. Elizabeth's Medical Center, Brighton
  • Dana-Farber Cancer Instiute - Merrimack Valley, Methuen
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT05375643

Resilience and Equity in Aging, Cancer, and Health (REACH)

  • Dana-Farber Cancer Institute, Boston
A’ fastadh
Aoisean 65 agus nas sine · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT04674267

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT04899908

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • Massachusetts General Hospital Cancer Center, Boston
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT05592626

BOLSTER: Learning New Skills to Thrive

  • Dana-Farber Cancer Institute, Boston
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Ògmh 2026 · NCT06936878

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Ògmh 2026 · NCT06040541

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Massachusetts General Hospital,, Boston
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 27 Cèit 2026 · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • Dana Farber Cancer Institute, Boston
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Cèit 2026 · NCT05379985

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

  • Massachusetts General Hospital, Boston
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Gibl 2026 · NCT07020221

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.